Review of China's top ten key pharmaceutical regulations and policies in 2022
2023-01-26: https: www.cphi.cn. 2023-01-26. 13: 42. Source: CPHI Pharmaceutical Online. Author: Dishui Sinan
For the pharmaceutical industry, this year is a year of comprehensive upgrading of China's drug regulatory system, NMPA and other regulatory authorities revised, introduced many heavy new regulations,
CPHI
12 hours ago
5 minutes read
EASTMONEY
14 hours ago
3 minutes read
"Pharmaceutical Speed Reading Society" Bayer and Nektar Inhaled Antibiotic Amikacin Phase III Clinical Failure
2023-01-26: Nov 27, 2017. /. Pharmaceutical information list Ping An good doctor proposed to raise $1 billion in IPO; published the results of the second phase III clinical study of LMTX. (R); Ms. Gratile Acetate can fight multiple drug-resistant bacteria; Ethan Smart received 55 million yuan in round A funding...
WUHANTY
18 hours ago
2 minutes read
Sihuan Pharmaceutical: Two non-PVC powder-liquid double-chamber bags have been included in the 2022 National Medical Insurance Catalog
2023-01-26: Original title: Sihuan Medicine: Two non-PVC powder double chamber bags were included in the 2022 National Medical Insurance Catalogue
On January 26, 2023, Sihuan Pharmaceutical (00460.HK) announced that two first and exclusive products jointly developed by Sihuan Pharmaceutical (00460.HK) and its
SOHU
18 hours ago
1 minute read
Zhongsheng Pharmaceutical: The company's non-public offering of A shares still needs to be approved by the China Securities Regulatory Commission. The company is concentrating on promoting the phase III clinical research of RAY1216 tablets
2023-01-26: On January 24, Zhongsheng Pharmaceutical said on the interactive platform that the company is continuing to promote the non-public offering of A-shares. The company has received the Notice of Second Feedback Opinions on the Review of Administrative Licensing Projects by the China Securities Regulatory
EASTMONEY
20 hours ago
1 minute read
Pfizer Announces Covid Vaccine Development Progress. The mRNA Vaccine Is Expected to Enter Clinical Trials by the End of April
2023-01-26: On April 10, Pfizer announced significant progress in global research into novel coronavirus disease (COVID-19). Since the COVID-19 outbreak, the company has been working with many partners in the healthcare innovation ecosystem to address the global healthcare crisis posed by COVID-19. In a press release
WUHANTY
21 hours ago
1 minute read
New technique used to identify culprits that trigger heart attacks
2023-01-26: Recently, researchers at the University of Manchester and the University of Hull developed a new method to identify irregular electrical "storm waves" in the heart. The related research, published in the international journal Computational Biology at the Public Library of Science, may help later researchers
WUHANTY
1 day ago
1 minute read
It is time to cure the "distortionally high sales expenses" in pharmaceutical companies!
2023-01-25: Some time ago, a news that the Ministry of Finance carried out the quality inspection of accounting information in the pharmaceutical industry in 2019 caused an uproar in the pharmaceutical industry and led to a sharp fall in capital market pharmaceutical sector stocks. According to media reports, sales
WUHANTY
1 day ago
3 minutes read
New developments in EZH2 inhibitors: two types have been approved, and Hengrui Medicine's SHR2554 has been included in the breakthrough treatment category
2023-01-25: https: www.cphi.cn. 2023-01-25. 14: 19. Source: CPHI Pharmaceutical Online. Author: Yi Yi
Overall, EZH2 inhibitors are mostly in the early stages of development. China's pharmaceutical companies are also active in the layout of this field, such as Hengrui Pharmaceutical, Sinovii, Haihe Pharmaceutical.
CPHI
1 day ago
2 minutes read
Delaying the new drug listing application for fixed increase? Response from Zhongsheng Pharmaceutical: Nonexistent
2023-01-25: Read Chuang / Shenzhen Business Daily reporter Ma Qiang
The Chinese New Year holiday is a rare leisure and entertainment time for Chinese people, but the reporter noticed that on the interactive platform "Interactive Easy" of the Shenzhen Stock Exchange, in response to many investors' questions about
FINANCE.EASTMONEY
1 day ago
2 minutes read
Three Key Challenges of Integrative Medicine in Pediatrics
2023-01-25: On the face of it, it is very cost-effective for users to buy integrated pediatric health care products and get high-quality private pediatric services. Outpatient visits are guaranteed and the average price can be discounted. This is exactly what insurers expect when designing such integrated healthcare
WUHANTY
1 day ago
1 minute read
Dextromethorphan Hydrobromide Oral Single Formulation Switched to Prescription Drugs - News - Tianya Pharmaceutical Network
2023-01-25: On December 27, the United States Food and Drug Administration announced that in order to ensure public drug safety, according to the "prescription drugs and over-the-counter drugs classification management method (trial)" (the former National Pharmaceutical Products Administration Order No. 10), approved
WUHANTY
1 day ago
1 minute read
A list of the latest research progress in the field of brain cognition - News - Tianya Medicine
2023-01-25: I hope readers enjoy the latest research on brain cognition presented in this issue.
1. Sci.Signal: The Key to Neural Network Formation During Brain Development
Recently, researchers from the Duquesas University School of Medicine discovered why brain cell connections are directed to differentiate
WUHANTY
1 day ago
8 minutes read
Hainan will adjust the medical insurance catalog-News-Tianya Medicine
2023-01-25: On July 17, the Department of Human Resources and Social Security of Hainan Province publicly solicited comments on the "Hainan Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalogue (2017 Edition) Adjustment Work Plan (Draft for Solicitation of Comments)," and
WUHANTY
2 days ago
2 minutes read
General Office of the State Council: The assessment of drug proportion and consumption proportion is gone! -News-Tianya Pharmaceutical Network
2023-01-24: Consumption ratio cancelled?
On January 30, 2019, the General Office of the State Council issued Opinions on Strengthening the Performance Appraisal of Level III Public Hospitals, requiring that the first national level III public hospital performance appraisal be completed by the end of December
WUHANTY
2 days ago
1 minute read
ZYZHAN
2 days ago
1 minute read
The employees of pharmaceutical production enterprises stick to their posts to ensure the supply of medicines
2023-01-24: CCTV News: This year's Spring Festival is China's first Spring Festival after the official implementation of the new coronavirus infection "type B ethyl tube." With the increase in demand for medical supplies, pharmaceutical manufacturers around the Spring Festival overtime to ensure the supply of drugs.
NEWS.CCTV
2 days ago
1 minute read
Jacosi announced the completion of the first patient administration, and Aurora. A inhibitors are popular with capital
2023-01-24: https: www.cphi.cn. 2023-01-24. 11: 26. Source: CPHI Pharmaceutical Online. Author: Ye Fenghong
Aurora. A, also known as Aurora kinase A, acts on both the MYC and Rb signaling pathways and is suitable for treating patients with Rb1 gene loss. Rb is a cancer suppressor gene equivalent to a "brake"
CPHI
2 days ago
3 minutes read
Inventory of 13 black technologies. Let ALS, Parkinson, and dementia no longer be scary-News-Tianya Medicine
2023-01-24: Frozen people, Parkinson's disease and Alzheimer's disease have been the three major problems plaguing neurologists. It happens that all three diseases fall into one category and can be collectively referred to as neurodegenerative diseases. Not only is the disease incurable but it can get worse over
WUHANTY
2 days ago
4 minutes read
Ipratropium Bromide Ipratropium Bromide Inhalation Aerosol Generic Category 4 Listing Application Accepted-News-天ya Pharmaceutical Network
2023-01-23: Recently, according to the official website of CDE, isopropyl bromide inhalation aerosol of Sichuan Primate Pharmaceutical Co., Ltd. has been accepted for imitation class 4 listing application In 2019, sales of terminal isopropyl bromide inhalers in public medical institutions in China exceeded 1 billion
WUHANTY
3 days ago
1 minute read